Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients
- PMID: 32125825
- PMCID: PMC8085836
- DOI: 10.1021/acsnano.0c00173
Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients
Abstract
Nanocarrier-based delivery systems can be used to increase the safety and efficacy of active ingredients in medical, veterinary, or agricultural applications, particularly when such ingredients are unstable, sparingly soluble, or cause off-target effects. In this review, we highlight the diversity of nanocarrier materials and their key advantages compared to free active ingredients. We discuss current trends based on peer-reviewed research articles, patent applications, clinical trials, and the nanocarrier formulations already approved by regulatory bodies. Although most nanocarriers have been engineered to combat cancer, the number of formulations developed for other purposes is growing rapidly, especially those for the treatment of infectious diseases and parasites affecting humans, livestock, and companion animals. The regulation and prohibition of many pesticides have also fueled research to develop targeted pesticide delivery systems based on nanocarriers, which maximize efficacy while minimizing the environmental impact of agrochemicals.
Keywords: agrochemical delivery; cancer; clinical trials; drug delivery; gene delivery; nanocarrier; nanomedicine; pest management; precision farming; veterinary medicine.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
Similar articles
-
The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.Curr Top Med Chem. 2024;24(8):686-721. doi: 10.2174/0115680266287101240214071718. Curr Top Med Chem. 2024. PMID: 38409730 Review.
-
Targeted Drug Delivery for Sustainable Crop Protection: Transport and Stability of Polymeric Nanocarriers in Plants.Adv Sci (Weinh). 2021 Jun;8(11):e2100067. doi: 10.1002/advs.202100067. Epub 2021 Mar 19. Adv Sci (Weinh). 2021. PMID: 34105269 Free PMC article.
-
Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.Curr Top Med Chem. 2019;19(27):2507-2523. doi: 10.2174/1568026619666191024170212. Curr Top Med Chem. 2019. PMID: 31775591 Review.
-
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.Int J Nanomedicine. 2020 Mar 3;15:1437-1456. doi: 10.2147/IJN.S236927. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32184597 Free PMC article. Review.
-
Rational nanocarrier design towards clinical translation of cancer nanotherapy.Biomed Mater. 2021 Mar 5;16(3). doi: 10.1088/1748-605X/abe35a. Biomed Mater. 2021. PMID: 33540386 Review.
Cited by
-
Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particles.iScience. 2024 Jul 5;27(8):110461. doi: 10.1016/j.isci.2024.110461. eCollection 2024 Aug 16. iScience. 2024. PMID: 39104409 Free PMC article.
-
Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects.Pharmaceutics. 2023 Jan 3;15(1):168. doi: 10.3390/pharmaceutics15010168. Pharmaceutics. 2023. PMID: 36678796 Free PMC article. Review.
-
Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments.Nanomaterials (Basel). 2022 Dec 19;12(24):4501. doi: 10.3390/nano12244501. Nanomaterials (Basel). 2022. PMID: 36558354 Free PMC article. Review.
-
Gold nanoparticles decorated with ovalbumin-derived epitopes: effect of shape and size on T-cell immune responses.RSC Adv. 2022 Jul 7;12(31):19703-19716. doi: 10.1039/d2ra03027f. eCollection 2022 Jul 6. RSC Adv. 2022. PMID: 35865201 Free PMC article.
-
Nano-pesticides: the lunch-box principle-deadly goodies (semio-chemical functionalised nanoparticles that deliver pesticide only to target species).J Nanobiotechnology. 2022 Jan 4;20(1):13. doi: 10.1186/s12951-021-01216-5. J Nanobiotechnology. 2022. PMID: 34983544 Free PMC article.
References
-
- Eder J; Herrling PL Trends in Modern Drug Discovery. In New Approaches to Drug Discovery; Nielsch U, Fuhrmann U, Jaroch S, Eds.; Springer International Publishing: Cham, 2016; pp 3–22. - PubMed
-
- Hogan G; Tangney M The Who, What, and Why of Drug Discovery and Development. Trends Pharmacol. Sci 2018, 39, 848–852. - PubMed
-
- Holohan C; Van Schaeybroeck S; Longley DB; Johnston PG Cancer Drug Resistance: An Evolving Paradigm. Nat. Rev. Cancer 2013, 13, 714–726. - PubMed
-
- Maeda H; Tsukigawa K; Fang J A Retrospective 30 Years after Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy—Problems, Solutions, and Prospects. Micro-circulation 2016, 23, 173–182. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical